Douglas Hughes
Director/Board Member presso IMMUNOVANT, INC.
Patrimonio netto: 3 M $ in data 31/01/2024
Provenienza dei contatti di primo grado di Douglas Hughes
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 28 | |
13
| Public Company | Medical Specialties | 13 |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA.
7
| Subsidiary | Biotechnology | 7 |
Calyxo, Inc.
 Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA.
6
| Holding Company | Medical Specialties | 6 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million.
5
| Subsidiary | Biotechnology | 5 |
Nellix, Inc.
 Nellix, Inc. Medical SpecialtiesHealth Technology Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA.
2
| Extinct | Medical Specialties | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Douglas Hughes tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| TELEFLEX INCORPORATED | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ENDOLOGIX, INC. | Medical Specialties | President Director/Board Member | |
| VAPOTHERM, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Ulthera, Inc.
 Ulthera, Inc. Medical SpecialtiesHealth Technology Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC. | Medical Specialties | Director/Board Member Director/Board Member | |
Acclarent, Inc.
 Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Medical Specialties | Founder President Sales & Marketing | |
Relievant Medsystems, Inc.
 Relievant Medsystems, Inc. Medical SpecialtiesHealth Technology Relievant Medsystems, Inc. develops treatment and technologies for chronic back pain. Its Intracept System solution is a minimally invasive procedure that uses radiofrequency energy delivered into the vertebral body of the spine to ablate the basivertebral nerve. Relievant Medsystems was founded by James C. Peacock, Jeffrey Charles Lotz, and Rex Peters in 2004 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Solace Therapeutics, Inc.
 Solace Therapeutics, Inc. Medical SpecialtiesHealth Technology Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Earlens Corp.
 Earlens Corp. Medical SpecialtiesHealth Technology Earlens Corp. develops medical devices. It offers EarLens Contact Hearing Device that uses light to transmit sound. Its earlens contact hearing device two components: a tympanic membrane transducer, which is nonsurgically placed deep in the ear canal on the eardrum, and a light-based behind-the-ear sound processor placed at the base of the ear canal. The company was founded in 1999 by Rodney C. Perkins and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
Aerin Medical, Inc.
 Aerin Medical, Inc. Medical SpecialtiesHealth Technology Aerin Medical, Inc. develops non-invasive medical devices. It offers improvement in snoring and nasal airflow during surgery. The company was founded by Scott Jordan Wolf and Andrew G. C. Frazier in 2011 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor Private Equity Investor Private Equity Investor | |
| Pepperdine University | College/University | Graduate Degree Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Undergraduate Degree | |
Lake Region Medical, Inc.
 Lake Region Medical, Inc. Engineering & ConstructionIndustrial Services Lake Region Medical, Inc. engages in the business of developing and manufacturing OEM devices; and supplying the medical device companies with minimally invasive delivery solutions. It also focuses on cardiovascular, stimulation therapy, neurovascular, and peripheral vascular applications. The company was founded on December 14, 2000 and is headquartered in Wilmington, MA. | Engineering & Construction | Chief Executive Officer Director/Board Member | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| NEVRO CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
| TRIVASCULAR TECHNOLOGIES INC | Medical Specialties | Director/Board Member Director/Board Member | |
Ebb Therapeutics, Inc.
 Ebb Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology Ebb Therapeutics, Inc. develops medical devices for the treatment of insomnia. It engages in the development of regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders. The company was founded by Eric A. Nofzinger in 2008 and is headquartered in Pittsburgh, PA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
ExploraMed Development LLC
 ExploraMed Development LLC Electronic Equipment/InstrumentsElectronic Technology ExploraMed Development LLC operates as a medical technology incubation company that provides medical device solutions. The firm’s services include tissue bulking in incontinence and GI Reflux, revascularization technologies including percutaneous coronary and peripheral bypass and cell injection technologies for cardiac regeneration, therapy for osteoarthritis called the Kinespring system and consumer wellness products for women’s health. The company was founded by Joshua Makower in 2004 and is headquartered in Mountain View, CA. | Electronic Equipment/Instruments | Founder Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Nob Hill Therapeutics, Inc.
 Nob Hill Therapeutics, Inc. Medical SpecialtiesHealth Technology Nob Hill Therapeutics, Inc. develops dry powder nebulizer (DPN) for the treatment of severe respiratory diseases, including non-cystic fibrosis bronchiectasis and lung infections. The company was founded in 2016 and is headquartered in Albuquerque, NM. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President Director of Finance/CFO | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
NC8, Inc.
 NC8, Inc. Medical/Nursing ServicesHealth Services NC8, Inc. provides health care services. The company is headquartered in Mountain View, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman | |
Patient Square Capital
 Patient Square Capital Investment ManagersFinance Patient Square Capital is an Independent Private Equity/Venture Capital firm founded by Jim Momtazee and Maria Walker. Patient Square Capital is headquartered in Menlo Park. | Investment Managers | Consultant / Advisor Private Equity Investor Private Equity Investor Private Equity Investor | |
| SOC TELEMED, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Revelle Aesthetics, Inc.
 Revelle Aesthetics, Inc. Medical SpecialtiesHealth Technology Revelle Aesthetics, Inc. is a privately held medtech company based in Mountain View, CA. Bright, and Jonathan Podmore. Revelle Aesthetics is committed to developing precision technologies that deliver meaningful results for women and reliable outcomes for physicians. The company's first device, avéli®, is FDA-cleared and TGA authorized for long-term reduction in the appearance of cellulite in the buttock and thigh areas of adult females as supported by clinical data demonstrating treatment benefits through one year of observation. The company was founded in 2018 by Joshua Makower, Earl A. The CEO is Caroline F. van Hove. | Medical Specialties | Founder Director/Board Member Chairman | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The private company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | General Counsel Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Bermuda | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 3 |
| Electronic Technology | 3 |
Posizioni
| Director/Board Member | 386 |
| Corporate Officer/Principal | 109 |
| Independent Dir/Board Member | 74 |
| Chairman | 51 |
| Undergraduate Degree | 47 |
Contatti più connessi
| Insiders | |
|---|---|
| Ryan Drant | 52 |
| Myrtle Potter | 41 |
| Juliet Bakker | 41 |
| Joshua Makower | 37 |
| Frank Torti | 35 |
| Brooke Seawell | 31 |
| Peter Bisgaard | 28 |
| Robert Goforth | 26 |
| Nina Richardson | 25 |
| Guido Neels | 25 |
| Geoff B. Pardo | 23 |
| Beverly A. Huss | 23 |
| Kevin O'Boyle | 21 |
| Atul Pande | 20 |
| George Migausky | 18 |
- Borsa valori
- Insiders
- Douglas Hughes
- Connessioni Società
